Coherus Oncology, Inc.
CHRSNasdaqCIK 1512762HealthcareFiscal year ends Dec 31
Reports and events: 278 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2908:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-119912 |
| 2026-08-2817:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-103316 |
| 2026-08-1717:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-097951 |
| 2026-08-1717:27 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-097949 |
| 2026-08-0517:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-091262 |
| 2026-08-0516:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091188 |
| 2026-06-1516:40 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-074090 |
| 2026-06-0108:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-068615 |
| 2026-05-1116:43 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-058703 |
| 2026-05-1116:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058666 |
| 2026-04-2008:26 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001104659-26-045251 |
| 2026-03-0916:56 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-025308 |
| 2026-03-0916:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-025293 |
| 2026-02-1716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-016378 |
| 2026-02-0408:40 ET | 8-K | 8.01 Other events | 0001104659-26-010065 |
| 2026-01-2317:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006307 |
| 2026-01-1309:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-003117 |
| 2025-11-1317:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-111484 |
| 2025-11-0617:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107852 |
| 2025-11-0616:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107780 |
| 2025-09-0809:54 ET | 8-K | 8.01 Other events | 0001558370-25-011911 |
| 2025-08-0716:55 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010803 |
| 2025-08-0716:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010802 |
| 2025-07-0316:10 ET | 8-K | 3.01 Delisting notice | 0001558370-25-009085 |
| 2025-06-1316:07 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-059351 |
| 2025-05-3016:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008294 |
| 2025-05-1216:59 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007418 |
| 2025-05-1216:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007410 |
| 2025-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001558370-25-005825 |
| 2025-04-2516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-005554 |
| 2025-04-2217:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-005157 |
| 2025-04-1408:00 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-004746 |
| 2025-04-0116:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004264 |
| 2025-03-1716:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003126 |
| 2025-03-1306:02 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-002842 |
| 2025-03-1016:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002595 |
| 2025-03-0408:32 ET | 8-K | 8.01 Other events | 0001558370-25-002117 |
| 2025-01-1316:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000167 |
| 2024-12-0416:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-24-016012 |
| 2024-12-0307:11 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-124881 |
| 2024-11-0616:31 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014648 |
| 2024-11-0616:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014642 |
| 2024-09-1317:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001558370-24-012783 |
| 2024-08-0816:39 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011629 |
| 2024-08-0816:23 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-011618 |
| 2024-07-0208:30 ET | 8-K | 1.01 Entry into a material agreement | 0001558370-24-009650 |
| 2024-06-2708:52 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009526 |
| 2024-06-0509:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-24-008918 |
| 2024-06-0416:05 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-008898 |
| 2024-05-2117:14 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001558370-24-008542 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:11 ET. Listed shows no prices and gives no investment advice.